IMAC Holdings, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia (NCT04385056) | IMAC Holdings, Inc. | 2020-12-15 |
Track IMAC Holdings, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.